前收市價 | 5.25 |
開市 | 5.50 |
買盤 | 3.60 |
賣出價 | 7.60 |
拍板 | 42.00 |
到期日 | 2024-09-20 |
今日波幅 | 5.25 - 5.50 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 138 |
Initial data from an early-stage study shows that treatment with Avidity's (RNA) experimental therapy could address the underlying cause of a rare muscle-weakening condition.
Avidity unveiled "impressive" results from a study of its treatment for a rare form of muscular dystrophy. The top biotech stock soared.
These two biotechnology stocks could be gearing up for a run.